menu search

Open society foundations announce 2023 soros justice fellows

New York, Nov. 03, 2023 (GLOBE NEWSWIRE) — The Open Society Foundations is pleased to announce the 2023 cohort of Soros Justice Fellows, which inclu...

November 3, 2023, 8:52 pm

Clearstar announces appointment of mike pritts as chief executive officer

New CEO brings a wealth of expertise to ClearStar with over 35 years of senior leadership experience in the software and technology sectors. Alpharett...

November 3, 2023, 8:50 pm

Collective audience begins trading under new nasdaq ticker symbol, caud

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Collective Audience, Inc. (Nasdaq:CAUD), a leading provider of digital consumer ...

November 3, 2023, 8:30 pm

Cornerstone funds announce continuing monthly distributions and reset distribution amounts for 2024

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Cornerstone Strategic Value Fund, Inc. (NYSE American: CLM) (CUSIP: 21924B302) and Cornerstone Total Retu...

November 3, 2023, 8:30 pm

Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance

In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer v...

November 3, 2023, 8:30 pm

Aligos therapeutics to host kol event to discuss alg-000184 phase 1, aasld late breaker data

November 16 Event to feature KOL perspective on Emerging HBV Therapies SOUTH SAN FRANCISCO, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — Aligos Therapeu...

November 3, 2023, 8:30 pm

Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance

In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer v...

November 3, 2023, 8:30 pm

Bdc weekly review: are bond swappers insulated from interest rate rises?

We take a look at the action in business development companies through the fourth week of October and h...

November 3, 2023, 8:19 pm

Mining at the crossroads: how energy grids, etfs and the halving will shape bitcoin’s biggest industry

The bitcoin mining industry will face more challenges and opportunities than ever over the next few mon...

November 3, 2023, 8:14 pm

Aud/usd back over 0.6500 in post-nfp dollar rout

The AUD/USD has pushed into a 2-month high as the US Dollar slumps post-NFP. Market sentiment has flipped firmly risk on as investors no longer fear m...

November 3, 2023, 8:14 pm

Uaw's tesla push could push musk into robotic car building faster, says ross gerber

Hosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the...

November 3, 2023, 8:13 pm

Sensei biotherapeutics reports favorable clinical data for sns-101 at 2023 sitc annual meeting

– Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharm...

November 3, 2023, 8:05 pm

Prime medicine reports third quarter 2023 financial results and provides business updates

— Presented new preclinical research across multiple programs, including proof-of-concept data from i...

November 3, 2023, 8:01 pm

Astec to present at baird’s 2023 global industrial conference

CHATTANOOGA, Tenn., Nov. 03, 2023 (GLOBE NEWSWIRE) — Astec Industries, Inc. (NASDAQ: ASTE) announced today that J...

November 3, 2023, 8:01 pm

Kineta reports third quarter 2023 financial results and provides corporate update

Announced positive KVA12123 monotherapy safety data from its ongoing phase 1/2 VISTA-101 clinical trial Enrolled the first patient of KVA12123 in comb...

November 3, 2023, 8:01 pm

Citigroup: can jane fraser save citi?

The inability to correct underlying issues identified in multiple consent orders going back years has c...

November 3, 2023, 7:45 pm

New preliminary clinical data on potential of opus aav-based gene therapy for rare inherited retinal disease to be presented at the american academy of ophthalmology annual conference 2023

Data to be presented as part of gene augmentation therapy presentation RALEIGH, N.C., Nov. 03, 2023 (GLOBE NEWSWIRE) — Opus Genetics, a patient-focu...

November 3, 2023, 7:43 pm

Taysha gene therapies: tsha-102's potential is a 'buy'

Taysha Gene Therapies is a biotech stock focused on developing gene therapies for monogenic CNS diseases, with its lead candidate TSHA-102 targeting R...

November 3, 2023, 7:41 pm

Fed's bostic: policy is likely in the right place given the economic outlook

Pleased with jobs number, it's consistent with the outlookHoping for minimal pain for the economyFed has time to watch and be patient with dat...

November 3, 2023, 7:41 pm

Adobe inc. (adbe) class action: robbins llp reminds investors of lead plaintiff deadline in case against adobe inc.

SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class a...

November 3, 2023, 7:33 pm


Search within

Pages Search Results: